CoChat

Inositols in PCOS

Open access
Kamenov, Zdravko, Gateva, Antoaneta · 2020 · Molecules

The DOI matches its Crossref record; 143 of the 147 references it cites were found in a registry or an index.

Abstract

(1) Background: Myoinositol (MI) and D-chiro-inositol (DCI) are involved in a number of biochemical pathways within oocytes having a role in oocyte maturation, fertilization, implantation, and post-implantation development. Both inositols have a role in insulin signaling and hormonal synthesis in the ovaries. (2) Methods: Literature search (with key words: inositols, myo-inositol, d-chiro-inositol, PCOS) was done in PubMed until Sept. 2020 and 197 articles were identified, of which 47 were of clinical trials (35 randomized controlled trials). (3) Results: Many studies have demonstrated that in patients with polycystic ovarian syndrome (PCOS) MI treatment improved ovarian function and fertility, decreased the severity of hyperandrogenism including acne and hirsutism, positively affected metabolic aspects, and modulated various hormonal parameters deeply involved in the reproductive axis function and ovulation. Thus treating with MI has become a novel method to ameliorate PCOS symptoms, improve spontaneous ovulation, or induce ovulation. The current review is focused on the effects of MI and DCI alone or in combination with other agents on the pathological features of PCOS with focus on insulin resistance and adverse metabolic outcomes. (4) Conclusions: The available clinical data suggest that MI, DCI, and their combination in physiological ratio 40:1 with or without other compound could be beneficial for improving metabolic, hormonal, and reproductive aspects of PCOS.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3390/molecules25235566

Cites

143 of 143 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 Role of insulin resistance in the development of polycystic ovarian syndrome (PCOS).
Figure 1 Role of insulin resistance in the development of polycystic ovarian syndrome (PCOS).CC BY · PubMed Central
Figure 2 (a) Effects of myoinositol and D-chiroinositol on glucose metabolism in PCOS (adapted from [68]). (b) Effects of myoinositol and D-chiroinositol on hormonal synthesis in PCOS.
Figure 2 (a) Effects of myoinositol and D-chiroinositol on glucose metabolism in PCOS (adapted from [68]). (b) Effects of myoinositol and D-chiroinositol on hormonal synthesis in PCOS.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

4 retracted

Research works printed but not linked: 4

  1. Ciotta, L., Iozza, I., Rubbino, G., Iemmola, A., Lizzio, I., Teodoro, M.C., and Palumbo, M. (2010, January 4–7). Treatment of hyperandrogenism by myo-inositol. Proceedings of the 14th World Congress of Gynecological Endocrinology, Firenze, Italy.
  2. Di Berardino, O.M., Monteleone, P., Valentino, V., Ruggiero, M., Papini, F., Cela, V., Artini, P.G., and Genazzani, A.R. (2010, January 4–7). Myo-inositol administration in pcos patients after IVF. Proceedings of the 14th World Congress of Gynecological Endocrinology, Firenze, Italy.
  3. Papaleo, E., De Santis, L., Baillargeon, J., Zacche, M., Fusi, F., Brigante, C., and Ferrari, A. (2008, January 6–9). Comparison of myo-inositol plus folic acid vs clomiphene citrate for first line treatment in women with polycystic ovary syndrome. Proceedings of the 24th Annual Meeting of ESHRE, Barcelona, Spain.
  4. Genazzani, 2020, Expert’s opinion: Integrative treatment with inositols and lipoic acid for insulin resistance of PCOS. Gynecol, Reprod. Endocrinol. Metab., 1, 146

Cited by

See all 100

Metadata

Authors
Kamenov, Z., & Gateva, A.
Affiliations
Alexandrovska Hospital (BG)
Corresponding author
Kamenov, Zdravko
Venue
Molecules
Publisher
MDPI AG
Published
2020-11-27
Volume
25
Issue
23
Pages
5566
ISSN
1420-3049 (ISSN-L)
OpenAlex
W3109824023
Cited by
100
References
147
Citations by year
2026: 12 · 2025: 18 · 2024: 15 · 2023: 29 · 2022: 14 · 2021: 12
FWCI
2.03
Type
journal article
Language
en
Open access
Locations
  • Molecules (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Topics
  • Health Sciences › Medicine › Reproductive Medicine › Ovarian function and disorders
  • Health Sciences › Medicine › Reproductive Medicine › Reproductive Biology and Fertility
  • Health Sciences › Medicine › Reproductive Medicine › Endometriosis Research and Treatment
Keywords
polycystic ovary syndrome, myo-inositol, D-chiro-inositol, insulin resistance, hyperandrogenism, hirsutism, acne, ovulation induction, ovarian function, fertility, insulin signaling, metabolic outcomes
MeSH terms
Animals, Female, Humans, Inositol, Ovulation, Polycystic Ovary Syndrome

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.